Key information

🔎 Fund Overview

AccuStem was founded in 2020 as a spinoff from Tiziana Life Sciences to commercialize a wide array of oncology products. While many organizations have focused on one of the three primary healthcare industry segments- pharmaceuticals, diagnostics or devices- our goal is to offer novel solutions across all sectors. Our proprietary diagnostic focuses on the relationship between stem cells and cancer biology. We believe this “stemness” concept will be applicable across all tumor types. And we will bring additional value to patients and their care team by offering ancillary testing that will provide a complementary and comprehensive suite of answers for treatment planning.